HCA Healthcare price target raised to $588 from $525 at Cantor Fitzgerald

Cantor Fitzgerald raised the firm’s price target on HCA Healthcare (HCA) to $588 from $525 and keeps an Overweight rating on the shares. HCA’s outlook supports another year of solid core growth, with initial clarity on eAPTC subsidy risk easing bear-case concerns, Cantor tells investors in a research note. Strong fundamentals and effective management reinforce the attractiveness of the provider setup, the firm says.